Skip to main content
. 2025 Apr 21;24:64. doi: 10.1186/s12937-025-01132-6

Table 2.

General characteristics of study subjects

Variables Spirulina group (n = 30) Placebo group (n = 30) P *
Age (year) 39 ± 4.38 38.77 ± 4.22 0.83
Height (m) 1.69 ± 0.09 1.68 ± 0.09 0.68
Weight (kg)
Baseline 76.86 ± 15.98 75.15 ± 13.17 0.65
End 76.55 ± 16.11 75.60 ± 13.33 0.80
BMI (kg/m2)

Baseline

End

26.72 ± 4.09

30.99 ± 3.45

26.57 ± 4.02

31.72 ± 4.52

0.88

0.49

Waist circumference (cm)

Baseline

End

90.13 ± 11.35

88.50 ± 11.55

89.85 ± 11.50

89.26 ± 11.82

0.92

0.80

Hip circumference (cm)

Baseline

END

104.20 ± 8.66

103.02 ± 8.62

103.90 ± 8.30

103.21 ± 1.39

0.89

0.93

Physical activity (MET/min/week)
Baseline

1784.28 ± 1809.25

922.50 (2384.25) **

2348.16 ± 1968.47

2303 (2988) **

0.32 #
End

1638.70 ± 1789.64

786.00 (1176.38) **

2585.58 ± 2872.76

2300 (2625) **

0.09 #
gender Female 17 (56.7) 16 (53.3) 0.79
Male 13 (43.3) 14 (46.7)
occupation Employee 9 (30) 6 (20) 0.46
Freelance 11 (36.7) 16 (53.3)
College student 1 (3.3) 0 (0)
Housewife 9 (30) 8 (26.7)
Education status Under diploma 4 (13.3) 4 (13.3) 0.52
Diploma 8 (26.7) 12 (40.0)
University graduated 18 (60) 14 (47.7)
Marital status Married 25 (83.3) 26 (86.7) 0.72
Single 5 (16.7) 4 (13.3)
Familial history of IBS No 21 (70) 19 (63.3) 0.58
Yes 9 (30) 11 (36.7)
Familial history of chronic disease No 22 (73.3) 20 (66.7) 0.57
Yes 8 (26.7) 10 (33.3)
Multivitamin Use No 25 (83.3) 27 (90) 0.45
Yes 5 (16.7) 3 (10)
Anxiety normal 5 (16.7) 7 (23.3) 0.32
Mild 1 (3.3) 2 (6.7)
Moderate 4 (13.3) 8 (26.7)
Severe 20 (66.7) 13 (43.3)
Stress Normal 2 (6.7) 3 (10) 0.90
Mild 3 (10) 4 (13)
Moderate 8 (26.7) 7(23)
High 17 (56.7) 16 (53)

Quantitative variables are expressed as mean ± SD/ **median (IQR) and qualitative variables are expressed as n (%)

*P-value resulted from independent samples t-test/ #Mann–Whitney U for continuous and chi-squared tests for categorical variable